Furthermore, the contribution of ILC plasticity to distinct stages of human IBD (e.g., remission, relapse, progression) remains unclear, as clinical studies primarily rely on cross-sectional analysis of colonic biopsies or peripheral blood, restricting the capacity for dynamic assessment. This evidence concerns the gene CCL27 and inflammatory bowel disease.